4-methyl-4-aza-3-oxopregnane-20-carboxylate has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadohama, N; Karr, JP; Murphy, GP; Sandberg, AA | 1 |
| Kadohama, N; Karr, JP; Kim, U; Murphy, GP; Sandberg, AA; Wakisaka, M | 1 |
2 other study(ies) available for 4-methyl-4-aza-3-oxopregnane-20-carboxylate and Cancer of Prostate
| Article | Year |
|---|---|
Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Cell Nucleus; Cytosol; Dihydrotestosterone; Humans; Kinetics; Male; Organ Culture Techniques; Oxidoreductases; Pregnanes; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred WF; Steroids, Heterocyclic; Testosterone | 1984 |
Retardation of prostate tumor progression in the Noble rat by 4-methyl-4-aza-steroidal inhibitors of 5 alpha-reductase.
Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Castration; Dihydrotestosterone; Male; Organ Size; Oxidoreductases; Pregnanes; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Steroids, Heterocyclic | 1985 |